AHK-Cu
AHK-Cu is a synthetic copper-binding tripeptide, closely related in structure to GHK-Cu but marketed specifically toward hair follicle research rather than general skin structure. It's important to know upfront that AHK-Cu's own independent, peer-reviewed research base is considerably smaller than GHK-Cu's, and much of what's said about it draws on comparison to its better-studied relative rather than dedicated studies of its own.
- Sequence
- 3 amino acids, complexed with a copper ion
- Half-Life
- Not well established; published data is limited
- Format
- Lyophilized powder
What Is AHK-Cu?
AHK-Cu is a synthetic tripeptide made of alanine, histidine, and lysine, bound to a copper ion. It's structurally close to GHK-Cu, sharing two of three amino acids and the same copper-binding mechanism, with alanine substituted for glycine at one position. Unlike GHK-Cu, which occurs naturally in the human body, AHK-Cu is a lab-designed compound, engineered specifically with hair follicle research in mind rather than being isolated from a natural source.
Marketing material for AHK-Cu frequently describes it as improving blood flow around hair follicles and supporting follicle-related signaling, in contrast to GHK-Cu's broader, more established role in collagen and general tissue structure. It's worth being direct that AHK-Cu's dedicated research literature is considerably thinner: most sources comparing the two peptides acknowledge that GHK-Cu has decades of published research behind it, while AHK-Cu's evidence base remains much more limited and less independently verified.
What AHK-Cu is Being Researched For?
Perifollicular Vascular Density
The main research claim specific to AHK-Cu is that it may increase blood vessel density around hair follicles, a proposed mechanism distinct from GHK-Cu's more general tissue-remodeling activity. Sources describing this research are largely secondary and vendor-adjacent rather than pointing to a specific, independently verifiable primary study.
Comparison Research Against GHK-Cu
Where AHK-Cu does appear in more careful research discussions, it's typically framed as a narrower, less-studied alternative or complement to GHK-Cu, used to explore whether follicle-specific signaling differs from GHK-Cu's broader skin and connective tissue effects.
How AHK-Cu Is Described as Working
A Shared Copper-Delivery Mechanism
AHK-Cu is described as sharing GHK-Cu's basic copper-binding and delivery mechanism, since both peptides carry a copper ion that can interact with copper-dependent enzymes in tissue. The proposed distinction is that AHK-Cu's structure directs this activity more specifically toward follicular blood vessels rather than the broader collagen-building activity associated with GHK-Cu.
A Mechanism Extrapolated From a Related Peptide
Because AHK-Cu's own dedicated research is thin, much of its proposed mechanism is reasoned by analogy to GHK-Cu's well-characterized copper delivery system rather than confirmed through independent study of AHK-Cu specifically.
Reconstitution and Handling
AHK-Cu is typically supplied as a lyophilized powder in a sealed vial and reconstituted with bacteriostatic water before use in a research setting. Water should be added slowly rather than injected directly into the powder, and the vial should be swirled, not shaken.
Since the amount of water used affects the concentration of the final solution, researchers often use a dosage calculator to work this out before mixing. Keel Bio's calculator is a commonly used tool for this. Once reconstituted, the solution is kept refrigerated to help preserve its stability.
Key Takeaways
AHK-Cu is best understood as a structural cousin of GHK-Cu, marketed specifically toward hair follicle research, but its own dedicated evidence base is genuinely thin compared to GHK-Cu's decades-deep literature. Anyone researching AHK-Cu should be clear that most of what's claimed about it extrapolates from GHK-Cu's better-characterized mechanism rather than reflecting independently confirmed findings on AHK-Cu specifically.
Frequently Asked Questions
What is AHK-Cu derived from?
It's a fully synthetic copper-binding tripeptide, structurally similar to GHK-Cu but engineered rather than isolated from a natural source.
How is AHK-Cu different from GHK-Cu?
They share two of three amino acids and the same copper-binding mechanism, but AHK-Cu is marketed more narrowly toward hair follicle research, while GHK-Cu has a much broader and better-established research base in skin and connective tissue.
What has AHK-Cu been studied for?
It's marketed for perifollicular vascular density and hair follicle signaling, though independently verifiable, peer-reviewed research specifically on AHK-Cu is limited.
Has AHK-Cu been tested in humans?
No verifiable human clinical trial data specific to AHK-Cu was identified.
Should AHK-Cu's claims be weighed the same as GHK-Cu's?
No. GHK-Cu has a substantial, citable research history spanning decades. AHK-Cu's claims rely more heavily on structural comparison to GHK-Cu and vendor marketing material than on independently confirmed studies of AHK-Cu itself.
Related Reading
For educational and research purposes only. Not medical advice. Always consult a licensed healthcare professional before starting any protocol.